Biogen tanks as opicinumab misses Phase II endpoints in MS trial
Biogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being developed as a potential...
Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab
Alexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients with refractory generalized myasthenia...
NATCO Pharma Limited receives USFDA tentative approval for Sorafenib Tablets, 200mg
Natco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug Application (ANDA) for Sorafenib...
Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs
Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and create a therapeutic platform...
Gather China & World Pharmaceutical Entrepreneurs, Create a New Chapter of Chinese Pharma Industry
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23, 2016.Bearing 15-year trust of the industry, CPhI& P-MEC...
Kyowa Hakko Kirin Announces Phase 2 Clinical Study of RTA 402 in CKD patients with type 2 diabetes in Japan
Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in Japan Kyowa Hakko Kirin...
Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc , Daiichi Sankyo Company, Limited...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...